Abiopharma

🔍 MORRIS NIGEL W (Director)

Company: Remitly Global, Inc. (RELY)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 11,000 shares of Common Stock at $25.59 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,871,056.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 20,000 shares of Common Stock at $26.2 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,851,056.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.70 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
• F2: Weighted average price. These shares were sold in multiple transactions at prices ranging from $25.93 to $26.68 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.